Eyegate Pharmaceuticals Company Profile (NASDAQ:EYEG)

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The Company is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: EYEG
CUSIP:

Key Metrics:

Previous Close: $1.72
50 Day Moving Average: $1.72
200 Day Moving Average: $2.67
52-Week Range: $1.31 - $5.10
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -1.83
P/E Growth: 0.00
Market Cap: $15.40M
Outstanding Shares: 8,951,000
Beta: 2.76

Additional Links:

Companies Related to Eyegate Pharmaceuticals:

Consensus Ratings for Eyegate Pharmaceuticals (NASDAQ:EYEG) (?)

Ratings Breakdown:	1 Hold Rating, 4 Buy Ratings
Consensus Rating:	Buy (Score: 2.80)
Consensus Price Target:	$9.00 (423.26% upside)

Analysts' Ratings History for Eyegate Pharmaceuticals (NASDAQ:EYEG)

Show:

Date	Firm	Action	Rating	Price Target
6/28/2016	Maxim Group	Reiterated Rating	Hold
6/13/2016	Rodman & Renshaw	Reiterated Rating	Buy
4/14/2016	Chardan Capital	Reiterated Rating	Buy
4/7/2016	Noble Financial	Initiated Coverage	Buy -> Buy	$10.00
2/1/2016	HC Wainwright	Reiterated Rating	Buy

(Data available from 10/1/2014 forward)

Earnings History for Eyegate Pharmaceuticals (NASDAQ:EYEG)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Eyegate Pharmaceuticals (NASDAQ:EYEG)

Current Year EPS Consensus Estimate: $-1.64 EPS
Next Year EPS Consensus Estimate: $-0.94 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.32)	($0.32)	($0.32)
Q2 2016	1	($0.33)	($0.33)	($0.33)
Q3 2016	1	($0.34)	($0.34)	($0.34)
Q4 2016	1	($0.35)	($0.35)	($0.35)

(Data provided by Zacks Investment Research)

Dividend History for Eyegate Pharmaceuticals (NASDAQ:EYEG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Eyegate Pharmaceuticals (NASDAQ:EYEG)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/15/2016	Stephen From	Insider	Buy	15,000	$1.49	$22,350.00
6/15/2016	Morton Goldberg	Director	Sell	15,000	$3.16	$47,400.00
6/10/2016	Ventech Capital Ii	Major Shareholder	Sell	28,600	$3.04	$86,944.00
6/8/2016	Ventech Capital Ii	Major Shareholder	Sell	29,400	$3.25	$95,550.00
6/7/2016	Morton Goldberg	Director	Sell	10,939	$3.31	$36,208.09
2/19/2015	(Innoven Partenaires S.A. Ipsa	Major Shareholder	Buy	366,667	$6.00	$2,200,002.00
2/19/2015	Paul G Chaney	Director	Buy	8,333	$6.00	$49,998.00

(Data available from 1/1/2013 forward)

Latest Headlines for Eyegate Pharmaceuticals (NASDAQ:EYEG)

Date	Headline
	Catching the Wonder of Investors: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG) www.duncanindependent.com - September 30 at 5:16 PM
	Interested Penny Stock Investors Keen on Shares of Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG) www.duncanindependent.com - September 28 at 4:49 PM
	Penny Stock Investors are Growing Curious About Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG) www.duncanindependent.com - September 28 at 9:50 AM
	Shares Of Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Expected To Hit $10 - Investor Newswire (NASDAQ:EYEG) www.investornewswire.com - September 26 at 9:39 AM
	Keen Investors Find News on Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG) www.duncanindependent.com - September 23 at 4:42 PM
	Under the Microscope, Zeroing in at Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG) www.duncanindependent.com - September 23 at 9:56 AM
	Analysts Take the Wheel on Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Shares and Where They Might Be Headed - Frisco Fastball (NASDAQ:EYEG) friscofastball.com - September 21 at 5:29 PM
	Penny Stock Investors Take an Interest in Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG) www.duncanindependent.com - September 21 at 5:29 PM
	EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference - EconoTimes (NASDAQ:EYEG) www.econotimes.com - September 21 at 5:29 PM
	EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference (NASDAQ:EYEG) finance.yahoo.com - September 21 at 9:10 AM
	Looking Ahead for Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:EYEG) friscofastball.com - September 20 at 8:47 AM
	Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development (NASDAQ:EYEG) www.streetinsider.com - September 15 at 5:19 PM
	Valeant Pharmaceuticals Intl Inc (VRX) Is One Step Ahead in Ophthalmology Treatment - Smаrt Stоck Nеws (NASDAQ:EYEG) www.smartstocknews.com - September 14 at 9:07 AM
	Active News in Reviews- Neuralstem (NASDAQ:CUR), MiMedx Group (NASDAQ:MDXG), Eyegate Pharmaceuticals ... - Seneca Globe (NASDAQ:EYEG) www.senecaglobe.com - September 14 at 9:07 AM
	Shares Gapping Up Pre-Trade: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Post News (NASDAQ:EYEG) www.kentuckypostnews.com - September 14 at 9:07 AM
	Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development - StreetInsider.com (NASDAQ:EYEG) www.streetinsider.com - September 14 at 9:07 AM
	Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License (NASDAQ:EYEG) www.streetinsider.com - September 13 at 9:48 AM
	Funds to Advance Pre-clinical Development of CMHA-S Ocular Bandage Film (NASDAQ:EYEG) globenewswire.com - September 13 at 9:48 AM
	EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense (NASDAQ:EYEG) finance.yahoo.com - September 13 at 9:48 AM
	EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437 (NASDAQ:EYEG) globenewswire.com - September 12 at 9:49 AM
	Consensus Estimates on Earnings & Stock Price in Focus for Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Shares - Frisco Fastball (NASDAQ:EYEG) friscofastball.com - September 10 at 9:31 AM
	EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference (NASDAQ:EYEG) finance.yahoo.com - September 6 at 9:46 AM
	2016 H2 diabetic macular edema pipeline market therapeutics assessment made available by top research firm (NASDAQ:EYEG) www.whatech.com - September 2 at 9:49 AM
	Diabetic Macular Edema Pipeline Market 2016 Therapeutics Research (NASDAQ:EYEG) www.newsmaker.com.au - August 31 at 4:51 PM
	BRIEF-Eyegate says selling stockholders may offer up to 871,000 shares of co's common stock (NASDAQ:EYEG) in.reuters.com - August 31 at 4:51 PM
	EYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program (NASDAQ:EYEG) finance.yahoo.com - August 29 at 4:51 PM
	Today's Watch List: Eyegate Pharmaceuticals (NASDAQ:EYEG ... - KC Register (NASDAQ:EYEG) www.kcregister.com - August 23 at 5:03 PM
	EYEGATE PHARMACEUTICALS INC Financials (NASDAQ:EYEG) finance.yahoo.com - August 23 at 5:03 PM
	Will Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Hit $10 Price Target? - Investor Newswire (NASDAQ:EYEG) www.investornewswire.com - August 22 at 9:35 AM
	BRIEF-Eyegate Pharma Q2 net loss $3.823 million - Reuters (NASDAQ:EYEG) www.reuters.com - August 11 at 6:12 AM
	EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update - GlobeNewswire (press release) (NASDAQ:EYEG) globenewswire.com - August 11 at 6:12 AM
	EYEGATE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:EYEG) biz.yahoo.com - August 10 at 5:08 PM
	EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:EYEG) finance.yahoo.com - August 10 at 5:08 PM
	2 Biotech Stocks News And Price Trends: Eyegate Pharmaceuticals (NASDAQ:EYEG), Halozyme Therapeutics ... - The Voice Registrar (NASDAQ:EYEG) voiceregistrar.com - August 2 at 5:07 PM
	Last Analysts Rating Review: Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) , Eyegate Pharmaceuticals, Inc ... - Street Updates (NASDAQ:EYEG) www.streetupdates.com - August 2 at 5:07 PM
	BRIEF-Eyegate Pharmaceuticals reports positive top-line data - Reuters (NASDAQ:EYEG) www.reuters.com - August 2 at 5:07 PM
	Biotechnology Stocks in Limelight: Inotek Pharmaceuticals Corp (NASDAQ:ITEK), Eyegate Pharmaceuticals Inc ... - Post Registrar (NASDAQ:EYEG) postregistrar.com - August 2 at 5:07 PM
	Analysts: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) stock is worth $8.67 - Review Fortune (NASDAQ:EYEG) reviewfortune.com - August 2 at 5:07 PM
	Biotech Stocks Start Off August with a Bang (NASDAQ:EYEG) www.schaeffersresearch.com - August 1 at 4:52 PM
	EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of … (NASDAQ:EYEG) finance.yahoo.com - August 1 at 9:45 AM
	EYEGATE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:EYEG) biz.yahoo.com - August 1 at 8:32 AM
	Is $10 Price Target Attainable For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)? - Investor Newswire (NASDAQ:EYEG) www.investornewswire.com - July 24 at 4:44 PM
	Eyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) Shorts Decreased by 4.26% After Short Covering - Press Telegraph (NASDAQ:EYEG) presstelegraph.com - July 21 at 8:28 AM
	Strong Sell Calls For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) At 0 - Investor Newswire (NASDAQ:EYEG) www.investornewswire.com - July 19 at 11:03 AM
	New Broker Ratings For Eyegate Pharmaceuticals, Inc. (EYEG) - FTSE News (NASDAQ:EYEG) www.ftsenews.co.uk - July 16 at 8:21 AM
	Eyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) Sellers Covered 22.05% of Their Shorts - Consumer Eagle (NASDAQ:EYEG) www.consumereagle.com - July 15 at 6:50 AM
	Eyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) Sellers Covered 22.05% of Their Shorts - Engelwood Daily (NASDAQ:EYEG) www.engelwooddaily.com - July 10 at 4:41 PM
	Is $10 Within Reach For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)? - Investor Newswire (NASDAQ:EYEG) www.investornewswire.com - July 10 at 4:41 PM
	Stock Dipping Down in Session: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Telanagana Press (NASDAQ:EYEG) telanaganapress.com - July 6 at 10:45 PM
	Increased Volatility Watch for: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Engelwood Daily (NASDAQ:EYEG) www.engelwooddaily.com - July 6 at 10:45 PM